HemaCare, A Charles River Company: About Us

Posted by

HemaCare Corporation

Learn how HemaCare’s vertically integrated solutions support research from the bench to bedside. This video highlights HemaCare’s state-of-the-art facility, and gives an overview of how HemaCare’s over 40 years of donor management expertise and apheresis collection experience play a crucial role in providing high quality cellular material for the development cell-based therapies. HemaCare has performed over 300,000 apheresis collections, developed the largest reliable and recallable donor pool, and adopted the most stringent quality standards in the industry to provide customers with the highest quality cells and tissues available today. As a result, HemaCare was involved with 100% of FDA-approved immunotherapies. HemaCare is committed to providing a best-in-class portfolio of high quality, customizable human cellular material and services to advance discoveries.